Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Irving
Irving Boime, St. Louis, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20100120677 | ACTIVITY OF RECOMBINANT EQUINE FOLLICLE STIMULATING HORMONE - The present invention provides methods of producing biologically active recombinant eFSH analogs and methods of increasing reproduction in mammals, particularly equine, using recombinant eFSH analogs. Also provided are methods of producing biologically active single chain recombinant eFSH. The recombinant eFSH analogs of the present invention increase superovulation, follicular development, embryo development, and reproductive efficiency in horses, cattle and other ungulates. | 05-13-2010 |
Irving Dardik, Califon, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080316782 | SYSTEM AND METHOD FOR PRODUCTING ANHARMONIC MULTI-PHASE CURRENTS - A system and method for producing anharmonic multi-phase currents wherein the harmonic component of an inverter is filtered and superimposed with a series of control pulses to create a control signal. The control signal is fed back to the inverter, causing the inverter to produce anharmonic multi-phase currents. | 12-25-2008 |
Irving Elyanow, Lexington, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100163471 | WATER DESALINATION PLANT AND SYSTEM FOR THE PRODUCTION OF PURE WATER AND SALT - The present invention discloses a desalination plant that operates with a sea water or brackish water feed and produces a concentrated and selectively improved salt reject stream and a pure water permeate stream from a first treatment section that is arranged to produce primarily water at high recovery using membrane desalination processes. The reject stream from the first treatment line has a component distribution that is substantially reduced in native di- and polyvalent scaling ions, essentially depleted of sulfate, has substantially higher total dissolved solids than a traditional sea water reverse osmosis reject, yet is suitable for thermal treatment processes. The system may be enhanced by monovalent salt components. The unit may be integrated with a second treatment section, in which the first reject stream is further concentrated, purified, and processed to produce a high purity salt product. | 07-01-2010 |
| 20110303607 | SEAWATER DESALINATION PLANT AND PRODUCTION OF HIGH PURITY SALT - The present invention discloses an integrated desalination and salt plant for the production of a salt or slurry product of high purity. The reject stream from the desalination plant is used as the feed stream for the salt plant. The salt plant feed stream is filtered to effectively remove sulfate, which prevents scale formation in the salt plant equipment. The filtering may also reduce the level of calcium, magnesium, bicarbonate, or other components of the feed which may also prevent scale formation in the salt plant equipment. The salt plant produces a high purity salt product without the use of chemical purification. | 12-15-2011 |
Irving Goldschneider, Avon, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110200562 | Chimeric Cytokine of IL-7 and Beta Chain of HGF and Methods of Use - The present invention relates to a single-chain or chimeric polypeptide comprising a cytokine and a growth factor linked by at least one amino acid residue, and wherein the chimeric polypeptide enhances the proliferation and/or differentiation of hematopoietic precursor cells. In particular the invention relates to, a chimeric polypeptide comprising the beta-chain of hepatocyte growth factor, and IL-7 linked by at least one amino acid, and wherein the chimeric polypeptide demonstrates pre-pro-B proliferation and growth stimulating activity. | 08-18-2011 |
Irving Hu, Laguna Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090287127 | CIRCUMFERENTIAL WALKER - An orthopedic device in the form of a circumferential walker includes a first member (posterior shell) and a second member (dorsal shell) corresponding to the first member. An outsole or plantar shell portion is attached to, or formed on or with the posterior shell. An expansion joint is positioned in the posterior shell or dorsal shell to expand to accommodate larger sized lower legs. The dorsal and posterior shells may include flexible or resilient edge portions to reduce pressure points and to further accommodate users having larger sized lower legs. The dorsal shell also includes a flexible or resilient connecting portion to accommodate users having larger ankles and feet and to reduce or eliminate the formation of a pressure point along the dorsal shell. Quick-connecting buckle assemblies can be provided to allow a user to quickly don and doff the orthopedic device. | 11-19-2009 |
| 20090287128 | ORTHOPEDIC DEVICES UTILIZING ROTARY TENSIONING - An orthopedic device has at least one flexible or rigid frame member contoured to generally correspond to an anatomical limb. The device also includes a tightening system having a dial tensioning device and at least one cable and/or strap connected to the dial tensioning device. The dial tensioning device has a rotary ratchet permitting incremental adjustment of the cable and/or strap. Adjustment of the dial tensioner in a first direction secures the frame member to the limb. | 11-19-2009 |
| 20120078148 | CIRCUMFERENTIAL WALKER - An orthopedic device in the form of a circumferential walker includes a first member (posterior shell) and a second member (dorsal shell) corresponding to the first member. An outsole or plantar shell portion is attached to, or formed on or with the posterior shell. A hinge mechanism is provided between the posterior and dorsal shells to allow the dorsal shell to be swung away from the posterior shell in order to accommodate an anatomical limb therein. Inflatable bladders having perspiration wicking channels and/or openings are provided within a liner for insertion between the posterior and dorsal shells. Quick-connecting buckle and retaining assemblies can be provided to allow a user to quickly don and doff the orthopedic device. | 03-29-2012 |
Irving Hu, Camarillo, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100010410 | VERSATILE ORTHOPAEDIC LEG MOUNTED WALKER - An orthopedic walker for mounting on the lower leg of a patient includes a walker base having a central area for receiving the foot of a patient and a spaced lower surface including an outer sole, and a pair of struts connected to the walker base. Each of the struts has a frame member of high strength material secured to the first end of the walker base and a supporting component integrally secured and adjacent to the frame member. The supporting component defines laterally extending side wings generally corresponding to the second end of the frame member, and is constructed from a material less rigid than the high strength material of the frame member. The supporting component has a main body and a border portion that are integrally secured and contiguous with one another. The border portion is formed from a material having a lower hardness than the material forming the main body. | 01-14-2010 |
Irving Memis, Vestal, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20080296054 | HIGH PERFORMANCE CHIP CARRIER SUBSTRATE - A multilayer chip carrier with increased space for power distribution PTHs and reduced power-related noise. In a multilayer chip carrier with two signal redistribution fanout layers, in addition to signal escape from near-edge signal pads at the first fanout layer, remaining signal pads are moved closer to the edge of the chip footprint. At the voltage layer below the first fanout layer, the remaining signal pads are moved again, closer to the edge of the chip footprint. In the second fanout layer, below the voltage layer, the remaining signal pads escape. The region where signal pads are moved provides increased space for power PTHs. | 12-04-2008 |
| 20080308923 | HIGH PERFORMANCE CHIP CARRIER SUBSTRATE - A multilayer chip carrier with increased space for power distribution PTHs and reduced power-related noise. In a multilayer chip carrier with two signal redistribution fanout layers, in addition to signal escape from near-edge signal pads at the first fanout layer, remaining signal pads are moved closer to the edge of the chip footprint. At the voltage layer below the first fanout layer, the remaining signal pads are moved again, closer to the edge of the chip footprint. In the second fanout layer, below the voltage layer, the remaining signal pads escape. The region where signal pads are moved provides increased space for power PTHs. | 12-18-2008 |
| 20100060381 | Mulit-layer embedded capacitance and resistance substrate core - A multi-layer imbedded capacitance and resistance substrate core. At least one layer of resistance material is provided. The layer of resistance material has a layer of electrically conductive material embedded therein. At least one layer of capacitance material of high dielectric constant is disposed on the layer of resistance material. Thru-holes are formed by laser. | 03-11-2010 |
| 20100167210 | MULTI-LAYER EMBEDDED CAPACITANCE AND RESISTANCE SUBSTRATE CORE - A multi-layer imbedded capacitance and resistance substrate core. At least one layer of resistance material is provided. The layer of resistance material has a layer of electrically conductive material embedded therein. At least one layer of capacitance material of high dielectric constant is disposed on the layer of resistance material. Thru-holes are formed by laser. | 07-01-2010 |
Irving Mizus, Chevy Chase, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20120109101 | SYSTEM FOR ACCESS INTO BODILY CAVITY - An assembly and method for percutaneous placement of a catheter comprising an elongated hollow catheter having a distal end and a reduced cross-section portion at a proximal end thereof. An introducer needle is slidably mounted over said catheter. The introducer needle has an elongated slit adapted to slide over the reduced cross-section portion to separate the needle from the catheter. A syringe may be attached to the proximal end of the catheter. Also, a valve may be attached to the catheter to permit easy collection of fluid. | 05-03-2012 |
Irving Rabowsky, Oxnard, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100269143 | System and Method for Satellite Enhanced Command, Control, and Surveillance Services Between Network Management Centers and Unmanned Land and Aerial Devices - A novel system and method for electronic delivery of command, control information to many land and aerial devices, simultaneously or individually, and transmission of video, audio, location, and other information from devices to user defined entities such as network management centers, and devices over defined geographic areas utilizing inter-connected communications satellites. Satellites receive data packets which may include command, control, monitoring, video, audio, sensor, graphics, response, and other data, redistributes them to multiple destination addresses within other systems and subsystems and radiates source power to devices. Display centers receive video, audio, and sensor data, stores the data files for playback on command, and creates maps utilizing geographic information software and other displays suitable for electronic displays. Operators are able to view and hear video camera output in real-time, or delayed, and issue commands, in any geographic area where devices are present. | 10-21-2010 |
Irving Ramirez-Erosa, Saskatoon CA
| Patent application number | Description | Published |
|---|---|---|
| 20110230430 | SAPONIN EXTRACT FROM SAPONARIA SPP. AND USES THEREOF - A saponin extract from | 09-22-2011 |
Irving Stal, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20110247296 | COLD FORMED JOIST - The present invention provides a cold formed joist that can be used in a variety of construction applications. The present cold formed joist consists of three elements, each formed from sheet metal: an upper chord, an intermediate web, and a lower web. These three elements can be produced in different dimensions. The upper chord further consists of a downwardly facing receiving channel adapted to receive the upper edge of the intermediate web, and two upwardly facing channels. The lower chord consists of an upwardly facing receiving channel that is adapted to receive the lower edge of the intermediate web. | 10-13-2011 |
| 20110247298 | Cold Formed Joist - The present invention provides a cold formed joist that can be used in a variety of construction applications. The present cold formed joist consists of three elements, each formed from sheet metal: an upper chord, an intermediate web, and a lower web. These three elements can be produced in different dimensions. The upper chord further consists of a downwardly facing receiving channel adapted to receive the upper edge of the intermediate web, and two upwardly facing channels. The lower chord consists of an upwardly facing receiving channel that is adapted to receive the lower edge of the intermediate web. | 10-13-2011 |
Irving Sucholeiki, Winchester, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080207607 | Heterotricyclic metalloprotease inhibitors - The present invention relates generally to azatriocyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors. | 08-28-2008 |
| 20080261968 | Heterobicyclic metalloprotease inhibitors - The present invention relates generally to azabicyclic containing pharmaceutical agents, and in particular, to azabicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azabicyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, which exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors. | 10-23-2008 |
| 20090312312 | Heterobicyclic Metalloprotease Inhibitors - The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors. | 12-17-2009 |
| 20100087420 | Heterotricyclic Metalloprotease Inhibitors - The present invention relates generally to azatriocyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors. | 04-08-2010 |
| 20100249102 | Heterotricyclic Metalloprotease Inhibitors - The present invention relates generally to azatriocyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors. | 09-30-2010 |
| 20110230452 | Compounds and methods for the treatment of pain and other diseases - The present invention relates generally to pharmaceutical agents, and in particular, to metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of dual acting MMP-2 and MMP-9 inhibiting compounds that exhibit increased potency, metabolic stability and/or reduced toxicity in relation to currently known MMP-2 and MMP-9 inhibitors for the treatment of pain and other diseases. Additionally, the present invention relates to methods for treating pain, addiction and/or withdrawal symptoms in a patient comprising administering to the patient a pain-reducing effective amount of a present compound. | 09-22-2011 |
| 20110257222 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN AND OTHER DISEASES - The present invention relates generally to alkyne containing pharmaceutical agents, and in particular, to phenylethynyl-thiophene based metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of MMP inhibiting compounds that exhibit increased potency, metabolic stability and/or reduced toxicity in relation to currently known MMP inhibitors for the treatment of pain and other diseases such as cancer. Additionally, the present invention relates to methods for treating pain in a patient comprising administering to the patient a pain-reducing effective amount of a present compound. | 10-20-2011 |
| 20120015920 | HETEROBICYCLIC METALLOPROTEASE INHIBITORS - The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors. | 01-19-2012 |
Irving Sucholelld, Winchester, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090137547 | Heterobicyclic metalloprotease inhibitors - The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors. | 05-28-2009 |